drugset / Trial / NCT07036952

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

NCT07036952

RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to learn if Omega-3 works to treat Polycystic ovary syndrome in women. It will also learn about the safety of drug Omega-3. The main questions it aims to answer are: Does Omega-3 lower the number of times participant to treat metabolic syndrome What medical problems do participants have when taking drug Omega-3.Researchers will compare drug Omega-3 to a placebo (a look-alike substance that contains no drug) to see if drug Omega-3 used to treat PCOS. Participants will: Take Omega-3 or a placebo every day for 3 months Visit the clinic once every 6 weeks for checkups and tests Keep a diary of their symptoms and menstrual history.

Timeline

Start
2025-04-22
Primary completion
2025-10-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 fatty acids Unknown 1 g Oral